SHANGHAI, April 1 (Reuters) - Chinese e-commerce giant Alibaba Group Holding Ltd has scrapped plans to inject its pharmacy business into a Hong Kong-listed affiliate, citing regulatory uncertainties over the deal as well as over China's broader healthcare industry.
Read more
No comments:
Post a Comment